Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal of Neuro-Oncology|March 1, 2021
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastomaMary Jane Lim-Fat, Kun Wei Song, J Bryan Iorgulescu, et al.Neuro-Oncology|March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse gliomaIsabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.Neuro-Oncology|June 7, 2022
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experienceAnurag Saraf, Torunn I Yock, Andrzej Niemierko, et al.Journal of Oncology Practice|January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain MassIsabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.Radiology|November 9, 2021
Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent GlioblastomaMohamed E El-Abtah, Michael R Wenke, Pratik Talati, et al.Nature Medicine|February 24, 2023
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trialIngo K Mellinghoff, Min Lu, Patrick Y Wen, et al.Neuro-Oncology Advances|June 16, 2021
MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastomaPratik Talati, Mohamed El-Abtah, Daniel Kim, et al.Cancers|July 12, 2025
Prognostic Features of Recurrent Midline and H3 K27M-Mutant GliomaStephen J Bagley, Yoshie Umemura, Joe S Mendez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismVarun V Prabhu, Neel S Madhukar, Coryandar Gilvary, et al.Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.Pageof 3